Oxacillin

This classification denotes a penicillin antibiotic with the molecular formula C19H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UH95VD7V76, chemically known as 5-methyl-3-phenyl-4-isoxazolyl penicillin, sodium but generally known as oxacillin, which bears US NIH Compound Identifier 4608. European Medicines Agency schedules Oxacillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09484MIG. The term OXACILLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules oxacillin in its Anatomical Therapeutic Chemical (ATC) Classification. OXACILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxacillin under HS 29411090 and SITC 54131. As of Q4 2014, OXACILLIN remains the US FDA Preferred Term for this commodity. Oxacillin bears US NLM identifiers UMLS ID C0029983 and NCI Concept Code C62063. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)C1C(NOC1C)C1CCCCC1.